To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Cremation
Tuesday 11th March 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, when the Environment Agency’s guidance on the operation of crematoria will be (a) published and (b) brought into effect.

Answered by Emma Hardy - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)

The final updated Process Guidance Note 5/2 (24) is under review.


Written Question
Cremation
Monday 10th March 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department for Environment, Food and Rural Affairs:

To ask the Secretary of State for Environment, Food and Rural Affairs, whether he has made an assessment of the potential impact of delays to the Environment Agency’s guidance on the operation of crematoria on relevant stakeholders.

Answered by Emma Hardy - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)

The final updated Process Guidance Note 5/2 (24) is currently being reviewed by Ministers.


Written Question
Prescription Drugs
Monday 24th February 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Answer of 27 January 2021 to Question 137239 on Prescription Drugs, what information his Department holds on the number of patients who have been prescribed drugs categorised under the (a) (i) clonazepam and (ii) other benzodiazepines, (b) z-drugs, (c) antidepressants, (d) opioids, (e) pregabalin and (f) gabapentin drug groups in the (A) last 12 months and (B) the previous 12 month period for which data is available.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The following table shows the number of items dispensed and claimed for reimbursement for each of the categories requested, covering the most recently published 12-month period and the 12 months prior:

Drug group

Financial year

Total number of items

Clonazepam

2022/23

1,048,081

2023/24

1,059,421

Other benzodiazepines

2022/23

7,156,845

2023/24

6,814,129

Clonazepam and other benzodiazepines

2022/23

8,204,926

2023/24

7,873,550

Z-drugs

2022/23

5,316,627

2023/24

5,113,574

Antidepressants

2022/23

86,263,722

2023/24

89,131,582

Opioids

2022/23

39,401,517

2023/24

39,046,206

Pregabalin

2022/23

8,775,699

2023/24

9,180,793

Gabapentin

2022/23

7,413,759

2023/24

7,408,375

Source: NHS Business Services Authority.

In addition, the following table shows the patient identifiable information for the number of items dispensed and claimed for reimbursement for each of the categories requested, for the most recently published 12-month period and the 12 months prior:

Drug group

Financial Year

Total number of unique identified patients

Percentage of items where the patient has been identified

Clonazepam

2022/23

85,613

98.22%

2023/24

85,191

98.16%

Other benzodiazepines

2022/23

1,253,962

97.06%

2023/24

1,186,001

97.01%

Clonazepam and other benzodiazepines

2022/23

1,324,792

97.21%

2023/24

1,256,941

97.17%

Z-drugs

2022/23

795,959


98.29%

2023/24

764,743


98.27%

Antidepressants

2022/23

8,563,148


99.16%

2023/24

8,747,095


99.22%

Opioids

2022/23

5,593,035


98.92%

2023/24

5,562,718


98.94%

Pregabalin

2022/23

786,403


99.36%

2023/24

823,231


99.41%

Gabapentin

2022/23

808,562


99.36%

2023/24

799,144


99.41

Source: NHS Business Services Authority.

Notes:

  1. for clonazepam and other benzodiazepines, this is the number of unique patients who have received any combination of clonazepam and/or other benzodiazepines, and no patient is counted twice even where multiple medications have been received;
  2. the figures for pregabalin and gabapentin refer to the combined category of gabapentinoids; and
  3. the data in this answer in both tables on opioids, is not directly comparable to data from the previous Parliamentary Questions, PQ137238 and PQ137239, referenced in the question, as these tables refer to opioids in general, while the previous Parliamentary Questions referred to opioid analgesics only.

Written Question
Prescription Drugs
Monday 24th February 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many prescriptions were issued for each drug categorised under the (a) (i) clonazepam and (ii) other benzodiazepines, (b) z-drugs, (c) antidepressants, (d) opioids, (e) pregabalin and (f) gabapentin drug groups in the (i) last 12 months and (ii) previous 12 month period for which data is available.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The following table shows the number of items dispensed and claimed for reimbursement for each of the categories requested, covering the most recently published 12-month period and the 12 months prior:

Drug group

Financial year

Total number of items

Clonazepam

2022/23

1,048,081

2023/24

1,059,421

Other benzodiazepines

2022/23

7,156,845

2023/24

6,814,129

Clonazepam and other benzodiazepines

2022/23

8,204,926

2023/24

7,873,550

Z-drugs

2022/23

5,316,627

2023/24

5,113,574

Antidepressants

2022/23

86,263,722

2023/24

89,131,582

Opioids

2022/23

39,401,517

2023/24

39,046,206

Pregabalin

2022/23

8,775,699

2023/24

9,180,793

Gabapentin

2022/23

7,413,759

2023/24

7,408,375

Source: NHS Business Services Authority.

In addition, the following table shows the patient identifiable information for the number of items dispensed and claimed for reimbursement for each of the categories requested, for the most recently published 12-month period and the 12 months prior:

Drug group

Financial Year

Total number of unique identified patients

Percentage of items where the patient has been identified

Clonazepam

2022/23

85,613

98.22%

2023/24

85,191

98.16%

Other benzodiazepines

2022/23

1,253,962

97.06%

2023/24

1,186,001

97.01%

Clonazepam and other benzodiazepines

2022/23

1,324,792

97.21%

2023/24

1,256,941

97.17%

Z-drugs

2022/23

795,959


98.29%

2023/24

764,743


98.27%

Antidepressants

2022/23

8,563,148


99.16%

2023/24

8,747,095


99.22%

Opioids

2022/23

5,593,035


98.92%

2023/24

5,562,718


98.94%

Pregabalin

2022/23

786,403


99.36%

2023/24

823,231


99.41%

Gabapentin

2022/23

808,562


99.36%

2023/24

799,144


99.41

Source: NHS Business Services Authority.

Notes:

  1. for clonazepam and other benzodiazepines, this is the number of unique patients who have received any combination of clonazepam and/or other benzodiazepines, and no patient is counted twice even where multiple medications have been received;
  2. the figures for pregabalin and gabapentin refer to the combined category of gabapentinoids; and
  3. the data in this answer in both tables on opioids, is not directly comparable to data from the previous Parliamentary Questions, PQ137238 and PQ137239, referenced in the question, as these tables refer to opioids in general, while the previous Parliamentary Questions referred to opioid analgesics only.

Written Question
Gambling: Advertising
Thursday 13th February 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department for Digital, Culture, Media & Sport:

To ask the Secretary of State for Culture, Media and Sport, whether she plans to consider evidence related to advertising when strengthening protections against gambling harms.

Answered by Stephanie Peacock - Parliamentary Under Secretary of State (Department for Culture, Media and Sport)

We are committed to considering the best available evidence, including on advertising, from a wide range of sources to inform decisions on strengthening protections. Developing quality evidence is a key priority for the statutory levy and funding will be directed towards high-quality, independent research to fill key gaps in the evidence base. This could include research on the impacts of advertising. We will continue to monitor developments in the evidence and take action when appropriate.


Written Question
Youth Work
Friday 31st January 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department for Digital, Culture, Media & Sport:

To ask the Secretary of State for Culture, Media and Sport, what steps her Department is taking to support youth work as a profession by providing (a) financial support for students and (b) fieldwork placements.

Answered by Stephanie Peacock - Parliamentary Under Secretary of State (Department for Culture, Media and Sport)

DCMS works with the National Youth Agency (NYA) to fund bursaries for individuals to obtain youth work qualifications. Since 2019, £4 million of funding has been provided to the NYA via the Youth Worker Bursary Fund, allowing over 2,500 individuals from underrepresented groups to gain a qualification.

We have committed to co-producing a new National Youth Strategy, which is an opportunity to look afresh at the support, recruitment and retention of youth workers. The Strategy will be published this summer.


Written Question
Youth Services
Friday 31st January 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department for Digital, Culture, Media & Sport:

To ask the Secretary of State for Culture, Media and Sport, if she will take steps to ensure there is a minimum level of provision for youth services.

Answered by Stephanie Peacock - Parliamentary Under Secretary of State (Department for Culture, Media and Sport)

Local Authorities have a statutory duty to secure, so far as is reasonably practicable, sufficient provision of educational and recreational leisure-time activities for young people in their area. We will be launching the Local Youth Transformation pilot this year, which will support local authorities to build back capacity in the youth space and improve local youth offers.

This government has also committed to co-producing a new National Youth Strategy. As part of the Strategy, we will be consulting closely with young people and the youth sector. The Strategy will be published this summer.


Written Question
Youth Workers: Licensing
Thursday 30th January 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department for Digital, Culture, Media & Sport:

To ask the Secretary of State for Culture, Media and Sport, if she will make an assessment of the potential merits of introducing a revocable license to practice for youth workers.

Answered by Stephanie Peacock - Parliamentary Under Secretary of State (Department for Culture, Media and Sport)

DCMS funds the National Youth Agency to maintain a voluntary register of JNC Level 6 qualified youth workers and provide support to youth workers and organisations around safeguarding and risk management via their Safeguarding Hub.

In November, this government committed to co-producing a new National Youth Strategy, which is an opportunity to look afresh at the training, recruitment and retention of youth workers. The Strategy will be published this summer.


Written Question
Gender Dysphoria: Puberty Suppressing Hormones
Wednesday 29th January 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the impact of the restriction of puberty blockers for the treatment of gender incongruence on the (a) physical and (b) mental health of young trans people.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

On 11 December 2024 the Government introduced The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024, which came into effect on 1 January 2025. Alongside this legislation the Government published a full impact assessment, which is available at the following link:

https://www.legislation.gov.uk/uksi/2024/1319/impacts


Written Question
Youth Services: Finance
Wednesday 22nd January 2025

Asked by: Cat Smith (Labour - Lancaster and Wyre)

Question to the Department for Digital, Culture, Media & Sport:

To ask the Secretary of State for Culture, Media and Sport, how much funding allocated to the National Citizen Service will be redistributed to youth services.

Answered by Stephanie Peacock - Parliamentary Under Secretary of State (Department for Culture, Media and Sport)

Funding allocations for specific programmes will be communicated in due course, following the completion of business planning.